Global High Content Screening Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028
“Global High Content Screening Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global high content screening market report has been segmented on the basis of product, application, end user, and region.
Global High Content Screening Market: Overview
High content screening is also known as high-content analysis. It is an analytical method using automated microscopy, visualization tools for extract quantitative data from cell populations, and multi-parameter for image processing. High content screening involves fluorescence imaging of samples and reports quantitatively on multiple parameters. High content screening technology integrate all aspects of drug discovery, including primary compound screening, post-primary screening, evaluation of ADME properties, and complex multivariate drug profiling.
Global High Content Screening Market: Dynamics
Increasing research and development activities for innovation and drug discovery for various diseases such as cancer, Alzheimer, Parkinson’s, etc. is a key factor expected to drive the revenue growth of the target market over the next 10 years. In addition, advancement in informatics solutions and imaging instruments, growing geriatric population, increasing health care expenditure, are some of the factors boosting the demand for the high content screening globally. Furthermore, rising awareness about health among the individuals is playing a very important role in increasing demand for high content screening for various applications.
However, high price of high content screening instruments as well as lack of knowledgeable and skilled professional are the factor expected to hamper the growth of the target market to a certain extent.
Global High Content Screening Market: Segment Analysis
On the basis of product segment, instrument is expected to hold largest market share. On the basis of application segment, toxicity studies segment is expected to witnessed highest revenue share. This is primarily to, increasing cases of adverse drug reactions in large number of patient pool. On the basis of end user segment, pharmaceutical and biotechnology companies is expected to register fastest CAGR over the forecast period, due to increasing research activities for biological research and drug discovery.
Global High Content Screening Market: Trends
The major manufacturers are adopting various growth strategies such as merges, new launch etc. as well as research activities are carried out for application of HCS for personalized medicine, these are the key trend witnessed in the target market.
For instance, In October 2016, GE Healthcare launched IN Cell Image Analysis Software, which offers a fully integrated automation solution for its equipment in high content screening.
Global High Content Screening Market: Regional Analysis
In 2018, the markets in North America is anticipated to hold for highest revenue share in the target market. This is due to improved medical facilities, growing awareness of government regarding healthcare wellness in countries in the region. However, the market in Asia Pacific is expected to witnessed highest growth rate over next 10 years, due to growing emphasis on research and development activities in the health care sector, rising disposable income, and increasing need of novel drugs for treatment of complex diseases in the Asia Pacific region.
Global High Content Screening Market Segmentation:
Segmentation by product:
- Cell Imaging and Analysis Systems
- Flow Cytometers
Segmentation by application:
- Primary and Secondary Screening
- Target Identification and Validation
- Toxicity Studies
- Compound Profiling
- Other Applications
Segmentation by end user:
- Pharmaceutical and Biotechnology Companies
- Academic and Government Institutes
- Contract Research Organizations
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2027 Revenue in US$
- GE Healthcare
- Danaher Corporation
- Perkinelmer, Inc.
- Thermo Fisher Scientific Inc.
- Becton, Dickinson and Company
- Biotek Instruments, Inc.
- Bio-Rad Laboratories, Inc.
- Tecan Group Ltd.
- Yokogawa Electric Corporation
- Genedata AG
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!